Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based ...
A study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.
In patients with heart failure, SGLT2 inhibitors after TAVI are associated with major risk reductions in a clinical trial ...
MedPage Today on MSN2d
IgA Nephropathy Drug With Novel Mechanism Wins FDA ApprovalThe FDA granted accelerated approval to atrasentan (Vanrafia) for the reduction of proteinuria in adults with primary ...
Oral semaglutide reduced risk for major adverse CV events by 14% in high-risk adults with type 2 diabetes regardless of SGLT2 ...
Safeguards Of Dapagliflozin's Half Billion USD Sales In China: Astrazeneca. Legal News and Analysis - China - Conventus Law ...
In March 2025, Shandong Suncadia Medicine Co., Ltd. conducted a phase II Clinical Study of Efficacy and Safety of HRS-1780 ...
It is imperative to maintain the use of sodium–glucose cotransporter‐2 inhibitors (SGLT‐2is ... We aimed to investigate whether timing of SGLT‐2 is before the index diagnosis of HF, and second, ...
Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand School of Biomedical Sciences, Queensland University of Technology, Brisbane, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback